Kennametal Inc. heads into the back half of its fiscal year with a fresh downgrade landing on the same day the stock posted its strongest weekly gain in months — a collision that captures the stock's divided setup perfectly.
The most immediate development is the Barclays move. This morning, the firm's analyst Julian Mitchell cut the rating from Equal-Weight to Underweight and slashed the price target from $40 to $33 — a move that carries extra weight given Barclays had only lifted that target from $28 to $40 back in February after the strong Q3 earnings print. The reversal is sharp. The $33 target is now 10.6% below Tuesday's closing price of $36.94, and it lands at the lower end of a desk that already skews cautious: JP Morgan also holds an Underweight at $40, while Jefferies downgraded to Hold from Buy earlier this month with a $47.50 target. The consensus sits at Hold, with four holds and three underperforms among the analysts tracked. The mean target of $37.64 implies barely 2% upside from here — hardly a ringing endorsement.
The options market has been equally cautious. The put/call ratio has climbed to 1.04, almost exactly at its 52-week high of 1.05 and running nearly one standard deviation above its 20-day average of 0.61. That is a meaningful shift: for most of April and early May, PCR was tracking below 0.25, reflecting indifference or mild bullishness. The rotation into puts began around May 11-12 and has persisted through this week, suggesting hedging demand built ahead of — and has continued through — the earnings release on May 6. With the next print scheduled for August 5, options traders are establishing a defensive lean well in advance.
Short interest tells a less alarming story, and that contrast matters. At 3.4% of free float — around 2.6 million shares — the short position is not extreme. It did jump roughly 11% over the past week, recovering from a dip in mid-May, but at the current level it remains well within normal range for an industrial mid-cap. The borrow market reinforces this reading: the cost to borrow has actually fallen sharply, dropping nearly 20% on the week to 0.35%, its lowest point in the 30-day history shown. Availability is exceptionally loose at over 2,100% — meaning roughly 22 shares are available to borrow for every one currently lent out. There is no squeeze dynamic, no scarcity, and no sign of aggressive short-side conviction.
Valuation has compressed on the way down this month, then partially recovered this week. The PE ratio dropped roughly 6.5 points over the past 30 days before bouncing back 0.19 points on the day; at 9.5x trailing earnings with an EV/EBITDA around 5.9x to 6.3x (depending on the estimate basis), the stock trades at a meaningful discount to industrial machinery peers. EPS momentum stands out as a genuine positive — the 30-day and 90-day momentum factor scores rank in the 97th-98th percentile — and the Q3 print delivered an 11.2% single-day surge, confirming the company can surprise to the upside when execution holds. The five-day fade of 6.5% after that same print, however, is a reminder that the buying impulse has not been sticky.
KMT outpaced most of its peer group this week. Closest correlates OSK gained 6.1% and IR added 3.5%, broadly tracking the rally in industrial names. LECO and ITW lagged, each posting gains below 2%. The relative strength in KMT this week — up 6.8% — came despite, not because of, analyst sentiment, which makes the Barclays downgrade arriving at the top of that move all the more pointed.
The key variable into August is whether the EPS momentum that drove the February and May surprises has durability. The analyst community appears split between those who think the recovery trade is largely priced at current levels and those holding out for further operational improvement. The next earnings print on August 5 is the next real test of which camp has it right.
See the live data behind this article on ORTEX.
Open KMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
